00:36:37
Unaccredited
Genomics-driven innovation as a catalyst for growth
- 17 mins 43 secs
Stephane Mattatia, Global Head of Derivatives Licensing and Thematic Indexes at MSCI, Caique Cardoso, ETF Specialist, Itau, Simon Barnett, Director of Life Sciences Research, ARK Invest will share how genomic innovation is creating opportunities for investors. These innovations encompass technological and scientific developments in DNA sequencing, gene editing, targeted therapeutics, bioinformatics, and agricultural biology.
Channel:
MSCI
People:
Simon Barnett, Caique Cardoso, Stephane Mattatia
Companies: ARC Investment Management, ITAU Asset Management, MSCI
Topics: Genomics,
Companies: ARC Investment Management, ITAU Asset Management, MSCI
Topics: Genomics,
Show More
Show Less
Related
-
-
00:13:34Unaccredited -
00:15:43Unaccredited -
00:26:21Unaccredited -
00:10:11Unaccredited -
00:41:37Unaccredited -
00:08:13Unaccredited -
00:30:23Unaccredited -
00:13:14Unaccredited -
00:11:35Unaccredited -
00:27:57Unaccredited -
00:22:08Unaccredited
In the realm of investing, a factor is any characteristic that can explain the risk and return performance of an asset. For over 40 years MSCI, starting with Barra, has researched factors to determine their effects on long term equity performance. MSCI has developed Factor Indexes and Factor Models in consultation with the world’s largest investors and has research backed by four decades of Factor data compiled by a 200+ global research team.
Visit Website
Read Research & Insights
Listen to MSCI Perspective Podcasts